FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000605747> ?p ?o ?g. }

• W2000605747 endingPage "255" @default.
• W2000605747 startingPage "245" @default.
• W2000605747 abstract "ObjectiveMicroRNAs (miRNAs) have been implicated in complex vertebrate developmental systems, such as hematopoiesis, and may play an integral role in the development of human cancers. Based on these observations, we investigated the contribution of miRNAs to acute myelogenous leukemia cell lineage-specific differentiation.Materials and MethodsTo facilitate the identification of miRNAs and their targets relevant to leukemic cell differentiation, changes miRNA expression were analyzed in the human leukemia cell line HL-60, which historically has been utilized to study lineage-specific changes in response to the differentiation agent 12-O-tetradecanoylphorbol-13-acetate (TPA).ResultsUsing this approach, we have identified a panel of TPA-induced miRNAs that are expressed coincident with HL-60 stereotypic morphological changes characteristic of monocytic differentiation. The transferrin receptor 1(TfR-1; CD71), whose surface expression is downregulated during TPA-mediated HL-60 cell differentiation, has been identified as a target of the TPA-induced miRNA miR-320. Cell culture experiments indicate that enforced miR-320 expression can suppress TfR-1 expression and cell proliferation.ConclusionTPA induces the expression of several miRNAs in HL-60 cells, one such miRNA (miR-320) contributes to downregulation of TfR-1 surface expression characteristically seen during HL-60 monocytic differentiation. Moreover, TfR-1–targeting miRNAs, such as miR-320, may have potential as novel therapeutic agents for cancer due to their inhibitory effects on cell proliferation. MicroRNAs (miRNAs) have been implicated in complex vertebrate developmental systems, such as hematopoiesis, and may play an integral role in the development of human cancers. Based on these observations, we investigated the contribution of miRNAs to acute myelogenous leukemia cell lineage-specific differentiation. To facilitate the identification of miRNAs and their targets relevant to leukemic cell differentiation, changes miRNA expression were analyzed in the human leukemia cell line HL-60, which historically has been utilized to study lineage-specific changes in response to the differentiation agent 12-O-tetradecanoylphorbol-13-acetate (TPA). Using this approach, we have identified a panel of TPA-induced miRNAs that are expressed coincident with HL-60 stereotypic morphological changes characteristic of monocytic differentiation. The transferrin receptor 1(TfR-1; CD71), whose surface expression is downregulated during TPA-mediated HL-60 cell differentiation, has been identified as a target of the TPA-induced miRNA miR-320. Cell culture experiments indicate that enforced miR-320 expression can suppress TfR-1 expression and cell proliferation. TPA induces the expression of several miRNAs in HL-60 cells, one such miRNA (miR-320) contributes to downregulation of TfR-1 surface expression characteristically seen during HL-60 monocytic differentiation. Moreover, TfR-1–targeting miRNAs, such as miR-320, may have potential as novel therapeutic agents for cancer due to their inhibitory effects on cell proliferation." @default.
• W2000605747 created "2016-06-24" @default.
• W2000605747 creator A5009692912 @default.
• W2000605747 creator A5019788466 @default.
• W2000605747 creator A5029537735 @default.
• W2000605747 creator A5040206124 @default.
• W2000605747 creator A5064465709 @default.
• W2000605747 date "2009-02-01" @default.
• W2000605747 modified "2023-09-27" @default.
• W2000605747 title "miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation" @default.
• W2000605747 cites W1499519856 @default.
• W2000605747 cites W1519692040 @default.
• W2000605747 cites W1537210834 @default.
• W2000605747 cites W1557510721 @default.
• W2000605747 cites W1564896848 @default.
• W2000605747 cites W1967103142 @default.
• W2000605747 cites W1981589031 @default.
• W2000605747 cites W1982129404 @default.
• W2000605747 cites W1983015819 @default.
• W2000605747 cites W1983826553 @default.
• W2000605747 cites W1991904257 @default.
• W2000605747 cites W1992331999 @default.
• W2000605747 cites W1996441871 @default.
• W2000605747 cites W1998351143 @default.
• W2000605747 cites W1999689481 @default.
• W2000605747 cites W2000730569 @default.
• W2000605747 cites W2001107505 @default.
• W2000605747 cites W2013342236 @default.
• W2000605747 cites W2015113703 @default.
• W2000605747 cites W2022912538 @default.
• W2000605747 cites W2032384033 @default.
• W2000605747 cites W2033088721 @default.
• W2000605747 cites W2039030099 @default.
• W2000605747 cites W2049332203 @default.
• W2000605747 cites W2050869737 @default.
• W2000605747 cites W2058901530 @default.
• W2000605747 cites W2059382687 @default.
• W2000605747 cites W2066053565 @default.
• W2000605747 cites W2069923423 @default.
• W2000605747 cites W2083381199 @default.
• W2000605747 cites W2087206434 @default.
• W2000605747 cites W2094794452 @default.
• W2000605747 cites W2099819774 @default.
• W2000605747 cites W2112192177 @default.
• W2000605747 cites W2113952988 @default.
• W2000605747 cites W2137257434 @default.
• W2000605747 cites W2138664009 @default.
• W2000605747 cites W2152183134 @default.
• W2000605747 cites W2153778988 @default.
• W2000605747 cites W2154261604 @default.
• W2000605747 cites W2408828038 @default.
• W2000605747 cites W2502759836 @default.
• W2000605747 doi "https://doi.org/10.1016/j.exphem.2008.10.002" @default.
• W2000605747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19135902" @default.
• W2000605747 hasPublicationYear "2009" @default.
• W2000605747 type Work @default.
• W2000605747 sameAs 2000605747 @default.
• W2000605747 citedByCount "116" @default.
• W2000605747 countsByYear W20006057472012 @default.
• W2000605747 countsByYear W20006057472013 @default.
• W2000605747 countsByYear W20006057472014 @default.
• W2000605747 countsByYear W20006057472015 @default.
• W2000605747 countsByYear W20006057472016 @default.
• W2000605747 countsByYear W20006057472017 @default.
• W2000605747 countsByYear W20006057472018 @default.
• W2000605747 countsByYear W20006057472019 @default.
• W2000605747 countsByYear W20006057472020 @default.
• W2000605747 countsByYear W20006057472021 @default.
• W2000605747 countsByYear W20006057472022 @default.
• W2000605747 countsByYear W20006057472023 @default.
• W2000605747 crossrefType "journal-article" @default.
• W2000605747 hasAuthorship W2000605747A5009692912 @default.
• W2000605747 hasAuthorship W2000605747A5019788466 @default.
• W2000605747 hasAuthorship W2000605747A5029537735 @default.
• W2000605747 hasAuthorship W2000605747A5040206124 @default.
• W2000605747 hasAuthorship W2000605747A5064465709 @default.
• W2000605747 hasBestOaLocation W20006057471 @default.
• W2000605747 hasConcept C104317684 @default.
• W2000605747 hasConcept C109159458 @default.
• W2000605747 hasConcept C127561419 @default.
• W2000605747 hasConcept C145059251 @default.
• W2000605747 hasConcept C148738053 @default.
• W2000605747 hasConcept C1491633281 @default.
• W2000605747 hasConcept C28328180 @default.
• W2000605747 hasConcept C32264632 @default.
• W2000605747 hasConcept C502942594 @default.
• W2000605747 hasConcept C54355233 @default.
• W2000605747 hasConcept C62112901 @default.
• W2000605747 hasConcept C81885089 @default.
• W2000605747 hasConcept C86803240 @default.
• W2000605747 hasConcept C95444343 @default.
• W2000605747 hasConceptScore W2000605747C104317684 @default.
• W2000605747 hasConceptScore W2000605747C109159458 @default.
• W2000605747 hasConceptScore W2000605747C127561419 @default.
• W2000605747 hasConceptScore W2000605747C145059251 @default.
• W2000605747 hasConceptScore W2000605747C148738053 @default.
• W2000605747 hasConceptScore W2000605747C1491633281 @default.
• W2000605747 hasConceptScore W2000605747C28328180 @default.

• next